Volume | 77,617 |
|
|||||
News | - | ||||||
Day High | 15.04 | Low High |
|||||
Day Low | 14.68 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
NeoGenomics Inc | NEO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
15.04 | 14.68 | 15.04 | 14.99 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,358 | 77,617 | $ 14.96 | $ 1,160,915 | - | 11.03 - 21.22 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
11:06:55 | 100 | $ 14.69 | USD |
NeoGenomics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.87B | 127.61M | - | 591.64M | -87.97M | -0.69 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
NeoGenomics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NEO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 15.56 | 16.12 | 14.68 | 15.33 | 663,829 | -0.87 | -5.59% |
1 Month | 13.69 | 16.12 | 13.34 | 14.63 | 893,713 | 1.00 | 7.30% |
3 Months | 16.45 | 17.49 | 13.34 | 15.01 | 810,820 | -1.76 | -10.70% |
6 Months | 18.16 | 21.22 | 13.34 | 16.23 | 963,653 | -3.47 | -19.11% |
1 Year | 18.23 | 21.22 | 11.03 | 15.70 | 913,206 | -3.54 | -19.42% |
3 Years | 37.58 | 54.74 | 6.00 | 17.69 | 1,174,260 | -22.89 | -60.91% |
5 Years | 23.30 | 61.57 | 6.00 | 23.08 | 1,048,441 | -8.61 | -36.95% |
NeoGenomics Description
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services. |